Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT05264467

Leukocyte and and Platelet-rich Fibrin Plasma for the Prevention of Anastomotic Leakage in Colorectal Anastomosis

Use of Leukocyte and and Platelet-rich Fibrin Plasma (L-PRF) for the Prevention of Anastomotic Leakage in Colorectal Anastomosis

Sponsor: Universidad de Concepcion

Conditions Anastomotic Leak Colorectal Surgery Platelet-Rich Fibrin

Interventions Platelet rich fibrin on colorectal anastomosis

Updated 4 times since 2022 Last updated: Feb 28, 2022 Started: Mar 12, 2018 Primary completion: Jul 9, 2021 Completion: Aug 10, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2/PHASE3 clinical study on Anastomotic Leak and Colorectal Surgery, this trial is completed. The trial is conducted by Universidad de Concepcion and has accumulated 4 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2/PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Apr 2022 — Jul 2024 [monthly]

Completed PHASE2_PHASE3

First recorded

Mar 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Universidad de Concepcion

Data source: Universidad de Concepcion

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Concepción, Chile